Helium-oxygen ventilation in the presence of expiratory flow-limitation: a model study.
A comparison between air and heliox (80% helium-20% oxygen) ventilation was performed using a mathematical, non-linear dynamic, morphometric model of the respiratory system. Different obstructive conditions, all causing expiratory flow limitation (EFL), were simulated during mechanical ventilation to evaluate and interpret the effects of heliox on tidal EFL and dynamic hyperinflation. Relative to air ventilation, intrinsic positive end-expiratory pressure did not change with heliox if the obstruction was limited to the peripheral airways, i.e. beyond the seventh generation. When central airways were also involved, heliox reduced dynamic hyperinflation (DH) if the flow-limiting segment remained in the fourth to seventh airway generation during the whole expiration, but produced only minor effects if, depending on the contribution of peripheral to total apparent airway resistance, the flow-limiting segment moved eventually to the peripheral airways. In no case did heliox abolish EFL occurring with air ventilation, indicating that any increase in driving pressure would be without effect on DH. Hence, to the extent that chronic obstructive pulmonary disease (COPD) affects primarily the peripheral airways, and causes EFL through the same mechanisms operating in the model, heliox administration should not be expected to appreciably reduce DH in the majority of COPD patients who are flow-limited at rest.
Brighenti
Chiara
C
Dipartimento di Elettronica, Informatica e Sistemistica, Università di Bologna, 47023 Cesena, Italy.
Barbini
Paolo
P
Gnudi
Gianni
G
Cevenini
Gabriele
G
Pecchiari
Matteo
M
D'Angelo
Edgardo
E
D005540:Forced Expiratory Flow Rates / Q000187:drug effects*; D006371:Helium / Q000008:administration & dosage*; D006801:Humans; D007320:Inspiratory Capacity / Q000187:drug effects*; D008176:Lung Volume Measurements / Q000379:methods; D008433:Mathematics; D008954:Models, Biological; D017711:Nonlinear Dynamics; D010100:Oxygen / Q000008:administration & dosage*; D012121:Respiration, Artificial / Q000379:methods*
D006371:Helium; C038949:heliox; D010100:Oxygen